SLFN11 and cancer: Our findings add important information on the action of SLFN11 beyond its recently described role; hence, we propose SLFN11 as a dual biomarker capturing simultaneously interconnected immunological and cancer cell–intrinsic functional dispositions associated with sensitivity to DDAs.